Interim Report January–March 2018

  • Revenue increased by 14.1% to €161.9m (€141.9m). Organic revenue grew by 13.3%.

  • Operating profit amounted to €8.1m (€6.8m), representing an operating margin of 5.0% (4.8%).

  • Net profit amounted to €9.4m (€4.4m), which represents a net profit margin of 5.8% (3.1%).

  • Cash flow from operating activities amounted to €6.6m (€8.8m).

  • Basic/diluted earnings per share (EPS) was €0.067 (€0.040).

  • EBITDA increased by 13.6% to €15.0m (€13.2m), corresponding to an EBITDA margin of 9.3% (9.3%).


€ millions (€m) Q1 2018 Q1 2017 Growth FY 2017
Revenue 161.9 141.9 14% 580.2
Operating profit 8.1 6.8 19% 28.8
Operating profit margin, % 5.0% 4.8% 5.0%
Net profit 9.4 4.4 114% 20.2
Net profit margin, % 5.8% 3.1% 3.5%
Earnings per share, € 0.067 0.040 68% 0.157
Diluted earnings per share, € 0.067 0.040 68% 0.157
EBITDA1 15.0 13.2 14% 55.0
EBITDA margin, %[1] 9.3% 9.3% 9.5%

[1] For Alternative Performance Meassure definitions and reconciliations, refer to note 6 

This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 (CET) on 26 April 2018. This interim report and other information about Medicover, is available at

For further information, please contact:

Paula Treutiger, Corporate Communications & Investor Relations, Director           

Phone: +46-73-66 6599

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenues around €580 million and 15,900 employees. For more information, go to


About Us

Medicover is a leading international healthcare and diagnostic services provider in Poland, Germany, Romania, Ukraine and certain other markets, primarily in Central and Eastern Europe (“CEE”). Additionally, Medicover is in the process of entering the fast-growing Indian healthcare market in order to expand its geographical footprint and further leverage its emerging markets capabilities. Medicover offers a broad range of healthcare services and a significant hub-and-spoke diagnostic laboratory network, supported by extensively developed proprietary software and information systems infrastructure. Medicover operates through two divisions: Healthcare Services and Diagnostic Services.